Mucositis

"Mucositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).

Descriptor ID	D052016
MeSH Number(s)	C06.405.205.798 C07.465.584
Concept/Terms	Mucositis Mucositis Mucositides

Below are MeSH descriptors whose meaning is more general than "Mucositis".

Diseases [C]
Digestive System Diseases [C06]
Gastrointestinal Diseases [C06.405]
Gastroenteritis [C06.405.205]
Mucositis [C06.405.205.798]
Stomatognathic Diseases [C07]
Mouth Diseases [C07.465]
Mucositis [C07.465.584]

Below are MeSH descriptors whose meaning is more specific than "Mucositis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mucositis" by people in this website by year, and whether "Mucositis" was a major or minor topic of these publications.

Bar chart showing 5 publications over 5 distinct years, with a maximum of 1 publications in 2007 and 2011 and 2014 and 2016 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	0	1	1
2011	0	1	1
2014	1	0	1
2016	0	1	1
2022	1	0	1

Below are the most recent publications written about "Mucositis" by people in Profiles.

Barry KK, Plumptre I, Bazewicz CG, Green BP, Treat JR, Hughes M, Morel KD, Wiss K, Liang MG. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series. Pediatr Dermatol. 2023 Jan; 40(1):90-95.

View in: PubMed
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Ros?e PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rud? R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, G?rl?v JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016 May; 3(5):e217-27.

View in: PubMed
Hari P, Aljitawi OS, Arce-Lara C, Nath R, Callander N, Bhat G, Allen LF, Stockerl-Goldstein K. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. Biol Blood Marrow Transplant. 2015 Dec; 21(12):2100-2105.

View in: PubMed
Gosselin KB, Feldman HA, Sonis AL, Bechard LJ, Kellogg MD, Gura K, Venick R, Gordon CM, Guinan EC, Duggan C. Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children. J Pediatr Gastroenterol Nutr. 2014 Jun; 58(6):709-14.

View in: PubMed
Sangha R, Davies AM, Lara PN, Mack PC, Beckett LA, Hesketh PJ, Lau D, Li T, Perkins N, Gandara DR. Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial. J Thorac Oncol. 2011 Dec; 6(12):2112-9.

View in: PubMed
Rehman Y, Bj?rnland K, Stensrud KJ, Farstad IN, Emblem R. Low incidence of enterocolitis and colonic mucosal inflammation in Norwegian patients with Hirschsprung's disease. Pediatr Surg Int. 2009 Feb; 25(2):133-8.

View in: PubMed
Allen AM, Elshaikh M, Worden FP, Bradford CR, Teknos TN, Chepeha DB, Tsien C, Dawson LA, Urba S, Wolf GT, Normolle D, Eisbruch A. Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer. Head Neck. 2007 Feb; 29(2):137-42.

View in: PubMed
Przekop PR, Tulgan H, Przekop AA, Glantz M. Adverse drug reaction to methotrexate: pharmacogenetic origin. J Am Osteopath Assoc. 2006 Dec; 106(12):706-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals